Topic

Articles

Pharmalex has launched the Biopharma Excellence brand, a new service line that combines the expertise of PharmaLex, ERA Consulting, and Biopharma Excellence.

Pharmalex Launches Major New Service Line, Biopharma Excellence

SGS is investing in a new E&L lab in Navi Mumbai, India, that will provide testing services.

SGS Invests in New E&L Laboratory in India

AION Labs will be a first-of-its-kind AI/pharma and computational biology innovation lab aimed at spearheading the adoption of AI technologies and computational science. 

AstraZeneca, Merck KGaA, Pfizer, and Teva Team up with Tech and Investment Leaders to Launch New Biotech Innovation Lab 

This acquisition grants Bionano access to BioDiscovery’s clinical software solution for variant analysis.

Bionano Genomics Acquires BioDiscovery Inc. for $100 Million

The collaboration between Intellia and SparingVision will work to develop genomic medicines for ocular diseases.

Intellia Therapeutics and SparingVision Announce Strategic Collaboration to Develop Novel Ocular Therapies Using CRISPR/Cas9 Technology

Element’s acquisition of Nanosyn is the latest in a series of moves made to strengthen the company’s North American presence.

Element Strengthens US Presence with Nanosyn Acquisition

Pacira’s acquisition grants them access to Flexion’s pain management portfolio.

Pacira BioSciences Acquires Flexion Therapeutics for $630 Million

Supernus will acquire Adamas’ Parkinson's disease treatment portfolio through a $400 million acquisition.

Supernus to Acquire Adamas Pharmaceuticals in $400 Million Deal

Pfizer may pay up to $630 million for access to Voyager’s novel AAV capsids in transgene research.

Pfizer Agrees to License Agreement with Voyager Therapeutics

The collaboration between Sunovion, Sumitomo Dainippon, and Otsuka will focus on four compounds designed to treat neuropsychiatric health conditions.

Deals, Development and Manufacturing